Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Overview of attention for article published in Menopause (New York, N.Y.), June 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,424 followers.

Ospemifene (modulador selectivo de los R estrogénicos) demuestra en fase 3 beneficios sobre la sequedad vaginal. http://t.co/pUkPS06w38

More potential treatment options for pain with intercourse related to dryness and atrophy. http://t.co/si7r7GFs

Novel SERM ospemifene found effective for vaginal problems associated with #menopause. http://t.co/2nXPpTJh via @ASRM journal

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.